Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with ...
M spin-off Solventum forecast annual profit above analyst estimates on Thursday, betting on strong sales of its wound care and surgical sterilization products. Minnesota-based Solventum is one of the ...
CDXS) on Thursday reported a loss of $10.4 million in its fourth quarter. On a per-share basis, the Redwood City, California-based company said it had a loss of 13 cents. The results did not meet Wall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results